Tocilizumab Suppliers & Bulk Manufacturers
Available Forms: IV injection, SQ Injection
Available Strengths: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Reference Brands: Actemra®(US); RoActemra®(EU)
Category: Anti Covid Medicines
Tocilizumab (brand: Actemra by Roche) is an IL-6 receptor antagonist approved in the US, EU, and several global markets for severe COVID-19 and rheumatoid arthritis. Available in IV and subcutaneous forms, it’s in high demand for hospital use. Global PharmaB2B networks link buyers with verified Tocilizumab exporters and manufacturers, offering compliant sourcing, secure logistics, and international distribution support.
Product Description: Tocilizumab (brand name Actemra or RoActemra) is a monoclonal antibody used to treat severe COVID-19 complications and autoimmune conditions like rheumatoid arthritis. Available in intravenous (IV) and subcutaneous (SC) forms, it comes in strengths such as 80 mg, 200 mg, 400 mg IV vials, and 162 mg SC pens/syringes. Approved in the US, EU, and global markets, Tocilizumab is in high demand for hospitals and critical care. Through trusted PharmaB2B platforms, buyers can connect with certified Tocilizumab manufacturers, exporters, and distributors, ensuring regulatory-compliant sourcing, bulk availability, and fast international delivery for institutional and government tenders.
Tocilizumab — third party manufacturing & bulk supply
Tocilizumab is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tocilizumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tocilizumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Baricitinib
Strength:
2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details
Nirmatrelvir / Ritonavir Tablet
Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Favipiravir Tablet
Strength:
200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
